BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cocker F, Chien Yee K, Palmer AJ, de Graaff B. Increasing incidence and mortality related to liver cancer in Australia: time to turn the tide. Aust N Z J Public Health 2019;43:267-73. [PMID: 30958629 DOI: 10.1111/1753-6405.12889] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Low ES, Apostolov R, Wong D, Lin S, Kutaiba N, Grace JA, Sinclair M. Hepatocellular carcinoma surveillance and quantile regression for determinants of underutilisation in at-risk Australian patients. World J Gastrointest Oncol 2021; 13(12): 2149-2160 [DOI: 10.4251/wjgo.v13.i12.2149] [Reference Citation Analysis]
2 Schell D, Ullah S, Brooke-Smith ME, Hollington P, Yeow M, Karapetis CS, Watson DI, Pandol SJ, Roberts CT, Barreto SG. Gastrointestinal Adenocarcinoma Incidence and Survival Trends in South Australia, 1990-2017. Cancers (Basel) 2022;14:275. [PMID: 35053439 DOI: 10.3390/cancers14020275] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Liu Y, Zheng J, Hao J, Wang RR, Liu X, Gu P, Yu H, Yu Y, Wu C, Ou B, Peng Z. Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019. Cancer Med 2022. [PMID: 35118819 DOI: 10.1002/cam4.4551] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gardi N, Ketkar M, McKinnon RA, Pandol SJ, Dutt S, Barreto SG. Down-regulation of metabolic pathways could offset the poor prognosis conferred by co-existent diabetes mellitus in pancreatic (head) adenocarcinoma. ANZ J Surg 2021. [PMID: 34514690 DOI: 10.1111/ans.17194] [Reference Citation Analysis]
5 Wang F, Mubarik S, Zhang Y, Wang L, Wang Y, Yu C, Li H. Long-Term Trends of Liver Cancer Incidence and Mortality in China 1990-2017: A Joinpoint and Age-Period-Cohort Analysis. Int J Environ Res Public Health 2019;16:E2878. [PMID: 31408961 DOI: 10.3390/ijerph16162878] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
6 Dasgupta P, Henshaw C, Youlden DR, Clark PJ, Aitken JF, Baade PD. Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:171. [PMID: 32185125 DOI: 10.3389/fonc.2020.00171] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 14.5] [Reference Citation Analysis]
7 Meng R, Chen JW, D'Onise K, Barreto SG. Pancreatic ductal adenocarcinoma survival in South Australia: time trends and impact of tumour location. ANZ J Surg 2021;91:921-6. [PMID: 33825297 DOI: 10.1111/ans.16767] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Amini M, Looha MA, Zarean E, Pourhoseingholi MA. Global pattern of trends in incidence, mortality, and mortality-to-incidence ratio rates related to liver cancer, 1990-2019: a longitudinal analysis based on the global burden of disease study. BMC Public Health 2022;22:604. [PMID: 35351047 DOI: 10.1186/s12889-022-12867-w] [Reference Citation Analysis]
9 Barreto SG, D'onise K. Pancreatic cancer in the Australian population: identifying opportunities for intervention. ANZ Journal of Surgery 2020;90:2219-26. [DOI: 10.1111/ans.16272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]